TERUMO CORP (TRUMF) Financials
TRUMF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 12.0 billion | 3.4 billion |
| Sept. 30, 2023 | 11.7 billion | 3.3 billion |
| June 30, 2023 | 11.6 billion | 3.2 billion |
| March 31, 2023 | 12.1 billion | 3.7 billion |
TRUMF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | 153.2 million | ? |
| Sept. 30, 2023 | 156.7 million | ? |
| June 30, 2023 | -53.2 million | ? |
| March 31, 2023 | 174.3 million | ? |
TRUMF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | 278.8 million |
| Sept. 30, 2023 | 245.2 million |
| June 30, 2023 | 206.2 million |
| March 31, 2023 | 181.0 million |
TRUMF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 1.3 billion | - | - |
| Sept. 30, 2023 | 1.4 billion | - | - |
| June 30, 2023 | 1.2 billion | - | - |
| March 31, 2023 | 1.4 billion | - | - |
TRUMF Shares Outstanding
TRUMF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 113.5 million | 122.7 million | 624.4 million | - |
| Sept. 30, 2023 | 125.4 million | 109.8 million | 554.0 million | - |
| June 30, 2023 | 132.2 million | 106.5 million | 556.9 million | - |
| March 31, 2023 | 147.0 million | 120.5 million | 570.1 million | - |
TRUMF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 1.7 billion | 797.7 million |
| Sept. 30, 2023 | 1.5 billion | 737.5 million |
| June 30, 2023 | 1.5 billion | 729.6 million |
| March 31, 2023 | 1.5 billion | 776.9 million |
TRUMF
Price: $17.53
Dividend Yield: 1.25%
Forward Dividend Yield: 0.47%
Payout Ratio: 18.04%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.46 USD
P/E Ratio: 38.11
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Japan
Market Capitalization: 26.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 21
DGR3: 3.79%
DGR5: 30.00%
DGR10: 30.00%